SUMMARY Using the rat middle cerebral artery occlusion model, alterations in the eicosanoid synthetic capacity of brain microvessels following ischemia were studied by radiochromatography. Brain microvessels of normal rats predominantly produced hydroxyacids with relatively small amounts of PGD 2 and PGE 2 from exogenous arachidonic acid. Confirmation that hydroxyacids and prostaglandins were products respectively of lipoxygenase(s) and cyclooxygenase was obtained by experiments using indomethacin and eicosatetraynoic acid. The eicosanoid synthetic capacity of the brain microvessel, especially of hydroxyacids, was significantly enhanced 24 and 72 hours after the onset of ischemia. Because this is the phase of maximum edema in the present model, enhanced eicosanoid production in the brain microvessel may be involved in the mechanisms that underly ischemic brain edema.
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Stroke Vol 16, No 1, 1985 BREAKDOWN of the blood-brain barrier (BBB) to plasma solutes such as proteins and electrolytes constitutes an essential mechanism underlying ischemic brain edema. In agreement with previous reports, M our studies of the rat middle cerebral artery (MCA) occlusion model revealed that there was a close correlation between the increases in the brain water and sodium contents throughout the development of ischemic brain edema. 5 Therefore, from a therapeutic point of view, it seems of utmost importance to identify those chemical factors that might affect the BBB permeability following ischemia.
Several compounds, such as cyclic AMP, biogenic amines, and the kallikrein-kinogen-kinin system, have been suggested to be possible candidates that might cause BBB permeability changes. 6 ' 7 However, with each of these compounds, inconsistent data have been reported. 78 In this respect, the hypothesis suggested by Demopoulos et al 9 seems of interest. They assumed that in the brain rendered ischemic, active oxygens are generated and these cause membrane disruption due to propagation of free radical reactions. This represents a form of lipid peroxidation due to non-enzymatic reactions. On the other hand, it was recently shown that another form of lipid peroxidation due to enzymatic reactions, namely, the arachidonate cascade, exists in the brain. Free arachidonic acid accumulates following ischemia, 10 " 12 and at least part of it is peroxidized via the arachidonate cascade. 13 " 15 Cyclooxygenase and lipoxygenase products, such as prostaglandins and leukotrienes, are known to possess multiple biological actions, which may be related to the occurrence of brain edema. 16 -17 In addition to these products, an oxi-dant, currently deemed as hydroxyl radical, is liberated in the conversion of PGG 2 to PGH 2 . 18> l9 Hydroperoxides (HPETEs) which can act as free radicals or may release more potent oxidants through the action of the hydroperoxidase associated with PG synthetase 19 are produced by lipoxygenases. Therefore, when the role of free radicals in ischemic brain edema is considered, it seems indispensable to investigate the activity of the arachidonate cascade following ischemia.
In the present study, the eicosanoid synthetic capacity of the cerebral microvessel obtained from hemispheres of normal or MCA-occluded rats was examined. Brain microvessels were specifically studied because they are reportedly rich in the enzymes comprising the arachidonate cascade, 20 " 22 and, mostly being parenchymal small vessels, it constitutes essential parts of the cerebral microcirculation as well as being the site of the BBB. The unilateral MCA occlusion in the rat was used as the model of cerebral ischemia, because it was shown to provide a well-reproducible pattern of edema development.
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Materials and Methods
Preparation of the Rat Brain Microvessel
Male Sprague-Dawley rats, weighing 250-300 g were subjected to unilateral MCA occlusion by the method described elsewhere. 5 Sixteen rats were successively operated on in a day, and they were sacrificed 24 and 72 hours later. Following brain perfusion with 100 ml of physiological saline from the heart at a pressure of 120 mmHg, the brain was rapidly removed and divided into its two hemispheres. The 16 hemispheres of the MCA-occluded or sham-operated side were assembled and used to prepare the brain microvessel. Such a procedure was repeated three to four times for each experimental group.
Preparation of the brain microvessel was carried out according to the method of Gesce et al 22 with minor modifications. All steps in the procedure were carried out in the cold (0-4°C). Briefly, each hemisphere was chopped with scissors in 10 volumes of 0.25 M-su-ISCHEMIC BRAIN EDEMA IN THE RAT: PART ll/Asano el al crose, 5 mM-EDTA, and 50 mM-Tris HC1 (pH 7.3). Then, the suspension was serially passed through nylon meshes having pore sizes of 670 /xm and 335 /nm, respectively. The filtrate was centrifuged at 3,500 g for 10 minutes, and the resultant precipitate was resuspended into the same buffer. Each 2.5 ml were layered on a discontinuous density gradient consisting of 1.0 M-, 1.3 M-, and 1.5 M-sucrose (3 ml each). Then the gradient was centrifuged at 58,000 g for 60 minutes. The subfraction at the bottom of the tube were collected and resuspended in the above-described buffer. Light and electron microscopic study revealed that the fraction mainly consisted of microvessels with a diameter of 10-50 /tm.
Metabolism of [ 14 C]-arachidonic Acid by the Rat Brain Microvessel
The metabolism of [ 14 C]-arachidonic acid by the rat brain microvessel was studied within the day of preparation as follows. 23 The microvessel (40-50 /x,g protein) was preincubated for 10 minutes at 37°C in 0.1 ml of 50 mM-Tris HC1 (pH 7.4) containing 10.0 mMglucose with or without drugs. After preincubation, 50 /x.1 of [
14 C]-arachidonic acid (0.2 /u,Ci: final concentration of 6.5 IJLM) were added to the incubation mixture, which was incubated for an additional 60 mfnutes at 37°C in the dark without agitation. The reaction was terminated by chilling, followed by quickly adding an appropriate amount of 1 N-HC1 to bring the pH of the reaction mixture to 3.0. Then the mixture was extracted two times with 8 ml of ethyl acetate. The resulting organic phase was evaporated to dryness with a stream of nitrogen. The residue was then dissolved in a small amount of ethanol and applied to a precoated silica gel thin-layer plate (60F 254 , Merck). Prostaglandins D 2 , E 2 , 6-keto-PGF la (Ran Biochem), arachidonic acid (Sigma), and [
I4 C]-TXB 2 (New England Nuclear, Boston, Mass.) were also applied to the plate. The plate was developed in ethyl acetate-iso-octane-acetic acidwater (11:5:2:10, organic phase). The plate was dried and scanned for its radioactivities by a radiochromatoscanner (TRM-1B, Aloka). Nonradioactive arachidonic acid and prostaglandin markers were visualized by spraying with phosphomolybdic acid in ethanol. The areas corresponding to authentic standard arachidonic acid, PGD 2 , PGE 2 , and 6-keto-PGF la were scraped off the plate directly into scintillation vials as was the remaining silica gel in each lane. Ten rnillili ters of scintillating fluid (Aquasol-2, New England Nuclear) were added, and the radioactivity in each sample was measured in a Beckman LS-150 liquid scintillation counter. The radioactivity in each zone was expressed as the percentage of the total counts per minute for the entire lane. Throughout this experiment, microvessels incubated for 10 minutes in boiling water were used as a blank. The numbers of rats used for the examination of the arachidonate metabolism of the brain microvessel were 64, 48, 224, and 128 for each experimental group of normal, 24 hours after sham-operation, 24 hours after MCA occlusion, and 72 hours after MCA occlusion, respectively.
Effects of Indomethacin and Eicosatetraynoic Acid on the Metabolism of [ 14 C]-arachidonic Acid of the Rat Brain Microvessel
To determine whether the eicosanoids produced by the brain microvessel are products of the arachidonate cascade, the normal microvessel was incubated with [
I4 C]-AA in the presence of indomethacin (10~4 and 10-5 M) or eicosatetraynoic acid (ETYA; 3 x 10~4 and 3 X 10~5 M). Thirty-two rats were used for each experiment.
Statistical Analysis
Values are expressed as means ± SEM. The statistical significance of differences between group means was evaluated by Student's unpaired two-tail t-test. A p value of less than 0.05 was considered significant.
Protein Estimation
The protein concentration of the rat brain microvessel suspension was determined according to the method of Lowry et al 24 with crystalline bovine serum albumin as standard.
Chemicals
ETYA was a kind gift from Nippon Roche Research Center. Indomethacin was purchased from Sigma (St. Louis, Mo.).
Results
Eicosanoid Synthetic Capacity of the Rat Brain Microvessel
A typical thin-layer chromatography pattern of eicosanoid production of the microvessels obtained from the normal and MCA-occluded rats (24 hours postoperatively) is shown in figure 1 . The percentage conversion of [ 14 C]-arachidonic acid is summarized in table 1. From these results, it became apparent that normal rat microvessels predominantly produced hydroxyacids (Rf 0.51) and PGE 2 (Rf 0.30). In the case of MCA-occluded rats (24 and 72 hours postoperatively), on the other hand, all the eicosanoids were shown to be markedly increased.
The addition of indomethacin to the incubation mixture caused a significant reduction of only the cyclooxygenase products, whereas ETYA significantly reduced all the products (table 2). Thus indomethacin did not significantly reduce lipoxygenase products (hydroxyacids), but ETYA did.
Discussion
Fatty acids comprising membrane lipids are liberated and accumulate in the brain following ischemia. 10 " 12 Although most of these free fatty acids are considered to be washed out of the brain or reacylated, conversion of arachidonic acid to prostaglandins via the arachidonate cascade 13-' 5 and/or to unidentified peroxides" has been shown to occur in various models. Because of the potent biological effects of prostaglandins, it has been suspected that the arachidonate cascade is involved in the genesis of ischemic brain edema.
The role of prostaglandins in brain edema has been studied in experiments in which indomethacin was used as an inhibitor of cyclooxygenase. These studies consistently failed to find evidence of a beneficial effect, 25 " 28 suggesting that cyclooxygenase products are not major factors in the production of edema. However, as indicated by a previous report 29 and the present result (table 2) , indomethacin in the dose range used in those experiments probably does not inhibit lipoxygenases. In addition, it is known that indomethacin increases the availability of arachidonic acid to lipoxygenases. 29 Therefore, even if the cyclooxygenase pathway may not be involved in the occurrence of ischemic brain edema, the role of the lipoxygenase pathway needs to be clarified.
The present study revealed that the cerebral microvessel of normal rats has the capacity to convert exogenous arachidonic acid to various prostaglandins and hydroxy (hydroperoxy) acids. The percent conversion of [ l4 C]-arachidonic acid to each product was in good agreement with the result of Geese et al. 22 Further, the eicosandid synthetic capacity of the brain microvessel was shown to be significantly enhanced following MCA occlusion. The study using ETYA and indomethacin (table 2) indicates that prostaglandins and hydroxyacids detected by the present method are products of cyclooxygenase and lipoxygenase, respectively. 23 Therefore, the present study suggests that the activities of both enzymes in the brain microvessel were enhanced following MCA occlusion. As this occurred during the period of 24-72 hours after MCA occlusion when the edema development was most rapid in the present model, 5 it is tempting to speculate that the enhanced eicosanoid synthesis in the brain microvessel is causally related to edema formation.
As with the results obtained with other models, the administration of indomethacin in the present model did not effect beneficially brain edema (unpublished data). Considering these results, cyclooxygenase products may not play a major role in the occurrence of brain edema also in the present model, although the measurement of each prostaglandin in situ is required before a conclusion is reached.
On the other hand, little has been known about the lipoxygenase activity or the kinds and actions of lipoxygenase products in the brain or the brain microvessel. In organs other than the brain, however, there is evidence that lipoxygenase products increase the vessel permeability. Leukotrienes C 4 and D 4 , which are lipoxygenase products, were shown to increase plasma exudation when injected into the skin. 30 In the perfused lung, lipoxygenase products enhanced transalveolar exudation. 31 Also, the inhibition of lipoxygenase activity by BW755C was shown to mitigate the inflammatory response of the ischemic myocardium. 32 These results together with the present data showing that the lipoxygenase activity of the microvessel was significantly enhanced concomittant to the edema development raise the possibility that the products of lipoxygenase rather than of cyclooxygenase are relevant to the pathogenetic mechanism underlying ischemic brain edema. In support of this view, we have previously observed that the intrathecal injection of 15-hydroperoxy-arachidonic acid(15-HPAA), a plant lipoxygenase product, caused prolonged vasospasm of the basilar artery in dogs associated with pronounced degenerative changes in the arterial endothelium. 33 Insomuch as the present study revealed that the enhancement of the eicosanoid synthetic capacity of the brain microvessel paralleled the development of brain edema following MCA occlusion in rats, their relationship obviously requires further elucidation. Among various eicosanoids, the role of lipoxygenase products which were shown to be the major eicosanoid products of the brain microvessel in the present study, would merit further investigation.
